Cargando…

Cytokine-induced killer cell therapy for advanced pancreatic adenocarcinoma: A case report and review of the literature

Patients with advanced pancreatic adenocarcinoma have a poor prognosis, and to date, no treatment method has had a significant impact on the disease. In general, the mean overall survival time of such patients receiving conventional chemotherapy and radiotherapy is <6 months. In the present case...

Descripción completa

Detalles Bibliográficos
Autores principales:	LI, WEI, XU, LIN PING, DI ZHAO, LING, WANG, LI, ZHANG, YONG, GAO, QUAN LI, MAI, LING
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629180/ https://www.ncbi.nlm.nih.gov/pubmed/23599807 http://dx.doi.org/10.3892/ol.2013.1200

Ejemplares similares

Efficacy of cytokine-induced killer cells in the treatment of elderly patients with metastatic pancreatic adenocarcinoma
por: Li, Wei, et al.
Publicado: (2015)

Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer
por: Wang, Zibing, et al.
Publicado: (2016)

Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells
por: Han, Lu, et al.
Publicado: (2016)

Effect of inhibition proliferation in human lung adenocarcinoma A549 cells by cytokine-induced killer cells
por: Li, Dengrui, et al.
Publicado: (2015)

Recent advances in targeted therapy for pancreatic adenocarcinoma
por: Fang, Yu-Ting, et al.
Publicado: (2023)

Hedgehog Signaling Non-Canonical Activated by Pro-Inflammatory Cytokines in Pancreatic Ductal Adenocarcinoma
por: Wang, Yuqiong, et al.
Publicado: (2016)

A dynamic transcriptomic atlas of cytokine-induced killer cells
por: Meng, Mingyao, et al.
Publicado: (2018)

Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer
por: Du, Hansong, et al.
Publicado: (2020)

Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells
por: Kim, Ji Sung, et al.
Publicado: (2015)

Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors
por: Li, Xiao-Dong, et al.
Publicado: (2014)

Clinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature review
por: Zhang, Yong, et al.
Publicado: (2017)

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis
por: Yuan, Xin, et al.
Publicado: (2021)

Inflammatory Cytokines and Radiotherapy in Pancreatic Ductal Adenocarcinoma
por: Ng, Sylvia S. W., et al.
Publicado: (2022)

Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspective
por: Zhang, Wu-Hu, et al.
Publicado: (2020)

Cord Blood-Derived Cytokine-Induced Killer Cellular Therapy Plus Radiation Therapy for Esophageal Cancer: A Case Report
por: Wang, Liming, et al.
Publicado: (2014)

Tailor‐Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma
por: Hu, Xi, et al.
Publicado: (2021)

MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer
por: Wang, Zibing, et al.
Publicado: (2015)

Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer
por: Shi, Liangrong, et al.
Publicado: (2012)

The combination therapy of high-intensity focused ultrasound with radiotherapy in locally advanced pancreatic carcinoma
por: Li, Yu-Jiang, et al.
Publicado: (2016)

Identifying Outcomes of Patients With Advanced Pancreatic Adenocarcinoma and RECIST Stable Disease Using Radiomics Analysis
por: Yang, Qiuxia, et al.
Publicado: (2022)

Polo-like kinase 1 is involved in apoptosis, invasion, and metastasis of pancreatic ductal adenocarcinoma
por: Mao, Yonghuan, et al.
Publicado: (2020)

Inhibition of Human Pancreatic Tumor Growth by Cytokine-Induced Killer Cells in Nude Mouse Xenograft Model
por: Kim, Ji Sung, et al.
Publicado: (2012)

Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer
por: Wang, Danhong, et al.
Publicado: (2014)

Advances in Molecular Profiling and Categorisation of Pancreatic Adenocarcinoma and the Implications for Therapy
por: Pihlak, Rille, et al.
Publicado: (2018)

Effect of anti-asthma Chinese medicine Chuankezhi on the anti-tumor activity of cytokine-induced killer cells
por: Zhao, Jing-Jing, et al.
Publicado: (2013)

Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment
por: Xie, Yunqing, et al.
Publicado: (2017)

Cytotoxic Function and Cytokine Production of Natural Killer Cells and Natural Killer T-Like Cells in Systemic Lupus Erythematosis Regulation with Interleukin-15
por: Lin, Syh-Jae, et al.
Publicado: (2019)

A Systematic Inflammation-based Model in Advanced Pancreatic Ductal Adenocarcinoma
por: Wu, Li-Xia, et al.
Publicado: (2019)

Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
por: Gao, He-Li, et al.
Publicado: (2020)

Somatic copy number alteration predicts clinical benefit of lung adenocarcinoma patients treated with cytokine-induced killer plus chemotherapy
por: Kou, Fan, et al.
Publicado: (2022)

Cytokine-induced killer cells are type II natural killer T cells
por: Gütgemann, Stefan, et al.
Publicado: (2007)

Cytokine-induced killer cells/natural killer cells combined with anti-GD2 monoclonal antibody increase cell death rate in neuroblastoma SK-N-SH cells
por: Zhang, Chi, et al.
Publicado: (2019)

Combination therapy of irreversible electroporation and cytokine-induced killer cells for treating mice bearing panc02 pancreatic-cancer xenografts
por: Wang, Baohua, et al.
Publicado: (2023)

Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer
por: Ma, Baozhen, et al.
Publicado: (2022)

Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Yako, Yandiswa Yolanda, et al.
Publicado: (2016)

Effects of interleukin-2 concentration and administration method on proliferation and function of cytokine-induced killer cells
por: Liu, Yali, et al.
Publicado: (2021)

Advanced T and Natural Killer Cell Therapy for Glioblastoma
por: Yoon, Wan-Soo, et al.
Publicado: (2023)

Adoptive Immunotherapy of Cytokine-Induced Killer Cell Therapy in the Treatment of Non-Small Cell Lung Cancer
por: Wang, Min, et al.
Publicado: (2014)

Clinical applications of dendritic cells–cytokine-induced killer cells mediated immunotherapy for pancreatic cancer: an up-to-date meta-analysis
por: Zhang, Yucai, et al.
Publicado: (2017)

Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma
por: SAIF, MUHAMMAD WASIF, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jce01nvdnlicga3ql57r647of4